Connect Biopharma Holdings Limited (CNTB) vs Gossamer Bio, Inc. (GOSS)
A side-by-side comparison of Connect Biopharma Holdings Limited and Gossamer Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTB
Connect Biopharma Holdings Limited
$0.94HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT
GOSS
Gossamer Bio, Inc.
$10.61HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT
Total return — CNTB vs GOSS
growth of $100 · dividends reinvested · last 6yCNTB -95.1% (-39.6%/yr)GOSS -98.6% (-50.9%/yr)CNTB compounded faster over this window
CNTB GOSS
CNTB vs GOSS: by the numbers
- •GOSS is the larger company ($65M vs $59M market cap).
- •Both run net losses; GOSS's is the smaller (-235.00% vs -86687.50% net margin).
Metrics side by side
Valuation
| Metric | CNTB | GOSS |
|---|---|---|
| P/S ratio | N/A | 1.22 |
| P/B ratio | 2.21 | N/A |
Profitability
| Metric | CNTB | GOSS |
|---|---|---|
| Gross margin | 100.00% | 99.56% |
| Operating margin | -90740.62% | -336.81% |
| Net margin | -86687.50% | -235.00% |
| ROE | -132.16% | N/A |
| ROIC | -136.77% | N/A |
Growth (annualized)
| Metric | CNTB | GOSS |
|---|---|---|
| Total return CAGR (5Y) | -47.22% | -59.51% |
Frequently asked
- How have CNTB and GOSS total returns compared?
- Over the past 5 years, CNTB delivered -47.22% and GOSS delivered -59.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.